Balance Sheet
AssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globe Life (GL) Cash & Equivalents (2016 - 2019)

Globe Life (GL) has disclosed Cash & Equivalents for 12 consecutive years, with $22.9 billion as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Cash & Equivalents rose 23991.59% year-over-year to $22.9 billion, compared with a TTM value of $22.9 billion through Dec 2021, up 23991.59%, and an annual FY2021 reading of $22.9 billion, up 23991.59% over the prior year.
  • Cash & Equivalents was $22.9 billion for Q4 2021 at Globe Life, up from $94.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $22.9 billion in Q4 2021 and bottomed at $88.6 million in Q1 2018.
  • Average Cash & Equivalents over 4 years is $5.8 billion, with a median of $106.7 million recorded in 2017.
  • The sharpest move saw Cash & Equivalents skyrocketed 55.67% in 2017, then soared 23991.59% in 2021.
  • Year by year, Cash & Equivalents stood at $118.6 million in 2017, then dropped by 25.26% to $88.6 million in 2018, then grew by 7.03% to $94.8 million in 2020, then skyrocketed by 23991.59% to $22.9 billion in 2021.
  • Business Quant data shows Cash & Equivalents for GL at $22.9 billion in Q4 2021, $94.8 million in Q4 2020, and $88.6 million in Q1 2018.